The global Deep Brain Stimulation (DBS) Systems Market was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, at a CAGR of 8.1% according to a new report by Emergen Research.
The global Deep Brain Stimulation (DBS) Systems Market was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, at a CAGR of 8.1% according to a new report by Emergen Research. Growing prevalence of neurological disorders, technological advancements in deep brain stimulation devices, and favorable reimbursement policies are the major factors driving the growth of this market.
The increased adoption of deep brain stimulation systems for the treatment of various neurological disorders is one of the key driving factors for the growth of this market. According to a report by World Health Organization (WHO), around 50 million people are suffering from dementia, which is expected to affect 82 million people by 2030. Moreover, the rising geriatric population globally is also one of the major factors responsible for the growth of this market. The global geriatric population was around 962 million in 2017 and is expected to reach 2.1 billion by 2050. According to the United Nations (UN), around 21% of the world’s population is expected to be aged 60 or over by 2050.
Minimally invasive surgical techniques have gained immense popularity in the last few decades. The development of endoscopes, which are fiber optic devices that can be inserted into the body through small incisions, has helped surgeons to perform various procedures with minimal damage to the surrounding tissues. This minimally invasive approach is also known as keyhole surgery or laparoscopic surgery.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/45
Deep brain stimulation (DBS) is a minimally invasive surgical procedure that involves the placement of electrodes in specific areas of the brain. These electrodes are connected to a pulse generator, which is implanted under the skin. The pulse generator sends electrical impulses to the electrodes, which in turn stimulate the specific area of the brain.
Deep brain stimulation is used to treat a variety of neurological disorders, such as Parkinson’s disease, epilepsy, and dystonia. It is also being investigated as a potential treatment for Alzheimer’s disease, depression, and obsessive-compulsive disorder.
Key Highlights from the Report
- Dual channel deep brain stimulation systems product segment accounted for the largest market share owing to its ability to treat a wide range of medical indications. For instance, in February 2019, the U.S. FDA approved Boston Scientific Corporation’s Vercise Deep Brain Stimulation (DBS) System for treatment of adults with Parkinson’s disease and essential tremor, which is projected to fuel the demand for dual channel DBS systems during the forecast period. The single channel deep brain stimulation systems segment is expected to grow at the highest CAGR during the forecast period.
- Single-channel deep brain stimulation device segment is expected to grow at the highest compound annual growth rate due to technological advances in the field of deep brain stimulation, which has resulted in the development of more sophisticated devices with higher efficacy and fewer side effects.
- Parkinson’s disease segment is expected to register the fastest revenue CAGR during the forecast period due to the well-established infrastructure for deep brain stimulation in the US and European countries. Also, favorable reimbursement policies and the presence of unmet needs are expected to fuel growth in this segment.
- Alzheimer’s disease is another major target indication for deep brain stimulation systems. According to the World Health Organization (WHO), around 50 million people worldwide were living with dementia in 2017, which is expected to increase to 82 million by 2030 and 152 million by 2050. The high prevalence of this disease and the lack of effective treatments are expected to drive the adoption of deep brain stimulation systems in the coming years.
- North America is expected to dominate the global market during the forecast period due to factors such as favorable reimbursement policies, well-established healthcare infrastructure, and a large patient pool. According to the Alzheimer’s Association, in 2019, around 6 million people were living with Alzheimer’s disease or other dementias in the US.
- The Asia Pacific is expected to be the fastest-growing region during the forecast period due to increasing government initiatives for dementia awareness, growing geriatric population base, and improving healthcare infrastructure. For instance, according to the Department of Health, in 2015, the authorities in Singapore proposed to spend SGD 400 million (US$ 274.4 million) on research and development for Alzheimer’s disease over the next five years.
- Key market players operating in the market include Abbott, Medtronic, Aleva Neurotherapeutics, NeuroPace, Cyberonics, Boston Scientific Corporation and Fisher Wallace among other companies.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/deep-brain-stimulation-system-market
Emergen Research have segmented Deep Brain Stimulation (DBS) Systems Market on the basis of product, application, end use and region:
Product Outlook (Revenue in Million USD; 2017–2027)
- Dual Channel
- Single Channel
Application Outlook (Revenue in Million USD; 2017–2027)
- Fluid Replacement
- Parkinson’s Disease
- Pain Management
- Obsessive-Compulsive Disorder (OCD)
- Epilepsy
- Essential Tremor
- Depression
- Dystonia
- Other
End Use Outlook (Revenue in Million USD; 2017–2027)
- Hospitals
- Ambulatory Care Centre
- Neurology Centers
- Others
Regional Outlook (Revenue in Million USD; 2017–2027)
- North America
- US.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/45
Explore More Reports Emergen Research:
Information Rights Management Market
Contract Research Organization Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-deep-brain-stimulation-systems-market